Definitive Healthcare Announces Timing of Its Second Quarter 2024 Financial Results Conference Call and Webcast
Baker Tilly and Definitive Healthcare Enhance Life Sciences Compliance
Definitive Healthcare Launches Redesigned Mobile App to Enhance Access to Healthcare Commercial Intelligence
Definitive Healthcare Corp. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Small-cap, Buy-rated Stocks With Positive Estimate Revision Factors - BofA
Definitive Healthcare Wins 2024 Databricks Healthcare and Life Sciences Partner of the Year Award
Definitive Healthcare Corp. (NASDAQ:DH) May Have Run Too Fast Too Soon With Recent 25% Price Plummet
Definitive Healthcare Publishes 2023 Sustainability Report
Express News | Definitive Healthcare Corp: Jason Krantz Will Continue to Serve on Board of Directors as Executive Chairman After CEO Transition.
Express News | Definitive Healthcare Appoints Kevin Coop as CEO for Next Phase of Company’s Growth
Definitive Healthcare Corp—Kevin Coop named CEO on May 20
Definitive Healthcare Corp—Kevin Coop named CEO on May 20
Express News | Definitive Healthcare Corp - on May 20 Appointed Kevin Coop to Position of Chief Executive Officer
Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH) and Sarepta Therapeutics (SRPT)
Definitive Healthcare Corp. (NASDAQ:DH) Q1 2024 Earnings Call Transcript
Definitive Healthcare Corp. (DH) Q1 2024 Earnings Call Transcript
Definitive Healthcare Is Maintained at Equal-Weight by Barclays
Definitive Healthcare Price Target Cut to $7.00/Share From $11.00 by Barclays
Deutsche Bank Adjusts Definitive Healthcare Price Target to $7 From $10, Maintains Hold Rating
Barclays Keeps Their Hold Rating on Definitive Healthcare Corp (DH)
Buy Definitive Healthcare Stock On Weakness, Analyst Says As Revised Outlook Appears Achievable